Fig. 3
From: Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
The alterations in hematological markers before and after treatment in patients with different genotypes of PAI-1 RBC, red blood cell counts; Hb, hemoglobin; HCT, hematocrit; WBC, white blood cell counts; L, lymphocyte counts; N, neutrophil counts; PLT, platelet counts; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; Fbg, fibrinogen; pre, pre-treatment; post, post-treatment *P < 0.05